Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Levis, M; Ravandi, F; Wang, ES; Baer, MR; Perl, A; Coutre, S; Erba, H; Stuart, RK; Baccarani, M; Cripe, LD; Tallman, MS; Meloni, G; Godley, LA; Langston, AA; Amadori, S; Lewis, ID; Nagler, A; Stone, R; Yee, K; Advani, A; Douer, D; Jedrzejczak, WW; Juliusson, G; Litzow, MR; Petersdorf, S; Sanz, M; Kantarjian, HM; Sato, T; Tremmel, L; Bensen-Kennedy, DM; Small, D; Smith, BD

Published Date

  • November 20, 2009

Published In

Volume / Issue

  • 114 / 22

Start / End Page

  • 325 - 326

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 51st Annual Meeting and Exposition of the American-Society-of-Hematology

Conference Location

  • New Orleans, LA

Conference Start Date

  • December 5, 2009

Conference End Date

  • December 8, 2009